PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Early life gene epimutation may cause breast cancer.

Early life gene epimutation may cause breast cancer.
2023-12-07
(Press-News.org) Research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.Research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.

Cancer is a major health challenge worldwide, affecting many lives. Despite progress in understanding its causes, most cancer forms, including breast cancer, continues to increase in many countries.

Scientists have been looking closely at both genes and the environment, trying to figure out what sets the stage for cancer. One interesting area of study is something called "epimutations." Instead of changes to the actual genes, these are changes in how our genes are turned on or off.

In a recent study investigators at the University of Bergen, in collaboration with the US Women's Health Initiative, the investigators found a link between certain epimutations in a gene called BRCA1 and a higher risk of triple-negative breast cancer (TNBC), the most severe type of breast cancer. 

“This higher risk was found despite the fact that epimutations affected a very small portion of normal cells in the affected individuals”, says professor Per Eystein Lønning.

May originate from the pregnancy.

While this was a breakthrough, it left the researchers wondering when and where these epimutations happen. In a new study now featured in the journal Genome Medicine the Bergen Group, and to be presented at the international SABCS, the worlds largest breast cancer conference in San Antonio on December 6, in collaboration with other Norwegian researchers, the Bergen researchers dug deeper. Analysing DNA from both breast tissue and white blood from over four hundred breast cancer patients, they made several important discoveries providing new light on the subject.

For many cases of TNBC, BRCA1 gene epimutations were found in both the white blood cells and tumour tissue. Moreover, epimutations in the white blood cells and tumour tissue from the same individual revealed the same profile.

“This suggests they might have a common cell origin, possibly occurring very early during pregnancy”, says Lønning.

 

Gender differences not previously recorded.

The findings also indicate that as many as around 20 per cent of all TNBC may arise from the small group of normal tissue cells carrying BRCA1 epimutations.

Analysing blood samples from newborns, they found similar BRCA1 epimutations as those detected in cancer patients. Surprisingly, these epimutations happened twice as often in girls than in boys. Finally, no concordance in epimutations between newborns and their parents was observed, arguing against direct inheritance.

“The fact that epimutations might be happening early during pregnancy challenges conventional theories on carcinogenesis and cancer risk. Moreover, the fact that they occur twice as common in girls than boys reveal an important gender difference not previously recorded”, says Lønning.

 

Could be a game changer.

This discovery is opening new avenues for research. The Bergen Breast Cancer Group now works on the exact mechanism of early life epimutations. In addition, in collaboration with WHI investigators, they study whether epimutations in other genes might be linked to other types of cancer.

“Understanding this could potentially be a game-changer in how we approach and prevent cancer in the future”, Lønning concludes.

 

 

 

END

[Attachments] See images for this press release:
Early life gene epimutation may cause breast cancer. Early life gene epimutation may cause breast cancer. 2 Early life gene epimutation may cause breast cancer. 3

ELSE PRESS RELEASES FROM THIS DATE:

The mechanism of ferroptosis and its related diseases

The mechanism of ferroptosis and its related diseases
2023-12-07
In a groundbreaking review titled "The Mechanism of Ferroptosis and its Related Diseases," Feng and his colleagues from the Department of Urology and the Institute of Urology, State Key Laboratory of Biotherapy, and Cancer Center at West China Hospital, Sichuan University, have undertaken a comprehensive investigation of ferroptosis and its intricate relationships with various diseases. This review not only discusses the mechanisms of ferroptosis and its associations with diseases but also underscores the pivotal role of compounds in targeting this regulated cell death process for therapeutic applications. Ferroptosis, initially identified by Dr. Brent R. Stockwell in 2012, gained ...

X-ray method enables micron-resolution imaging of living organisms over long time periods

X-ray method enables micron-resolution imaging of living organisms over long time periods
2023-12-07
WASHINGTON — Researchers have developed an X-ray imaging technique that can produce detailed images of living organisms with a much lower X-ray dose than previously possible. The advance enables small organisms or other sensitive samples to be studied at high resolution over much longer periods, which could reveal new insights into a variety of dynamic processes. The approach is based on phase contrast imaging, which relies not only on the absorption of X-rays in a sample, but also on the wave properties ...

Exercise may boost quality of life for patients with metastatic breast cancer

2023-12-07
SAN ANTONIO – Among patients with metastatic breast cancer, those who took part in a nine-month structured exercise program reported less fatigue and an improved quality of life compared to those who did not undergo the exercise program, according to results from the PREFERABLE-EFFECT trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023. Breast cancer and its treatments can cause side effects, such as fatigue, nausea, pain, and shortness of breath, which can decrease a patient’s health-related quality of life (HR-QoL). For patients with metastatic ...

Patients with HR-positive breast cancer may use fertility preservation and assisted reproductive technologies without increased risk of recurrence

2023-12-07
Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact three-year cancer recurrence rates among patients with hormone receptor (HR)-positive breast cancer who paused endocrine therapy to become pregnant, according to results from the POSITIVE trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023. “With the increasing age of childbearing, it is becoming more likely that women will be diagnosed with breast cancer before starting or completing their families,” said Hatem A. Azim Jr., MD, ...

Younger postmenopausal patients with early-stage breast cancer may be able to safely omit adjuvant radiotherapy

2023-12-07
SAN ANTONIO – Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years after surgery, according to results from the IDEA clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023. Results were simultaneously published in the Journal of Clinical Oncology. Patients who are diagnosed with stage I HR-positive breast cancer typically undergo breast-conserving surgery followed by adjuvant radiotherapy and endocrine therapy to reduce ...

Using machine learning to monitor driver ‘workload’ could help improve road safety

2023-12-07
Researchers have developed an adaptable algorithm that could improve road safety by predicting when drivers are able to safely interact with in-vehicle systems or receive messages, such as traffic alerts, incoming calls or driving directions. The researchers, from the University of Cambridge, working in partnership with Jaguar Land Rover (JLR) used a combination of on-road experiments and machine learning as well as Bayesian filtering techniques to reliably and continuously measure driver ‘workload’. Driving in an unfamiliar area may translate ...

Manipulation of gut microbiota with flaxseed could reduce breast cancer risk

2023-12-07
Washington, D.C.— A new study demonstrates that the human gut microbiome may be a factor in breast health. Lifestyle and diet have long been known to affect human health. In the study, flaxseed components called lignans were shown to influence the relationship between gut microorganisms and the expression of mammary gland microRNAs (miRNAs). A subset of these miRNAs regulates the genes involved in breast cancer, including genes that control cell proliferation and migration. The study was published in Microbiology Spectrum, a journal of the American Society for Microbiology. “The ...

Most of the world’s countries receive failing grade in global ‘human rights report card’

2023-12-07
KINGSTON, R.I. —Dec. 7, 2023—A new report that grades all the countries of the world on their respect for human rights paints a grim picture of human rights practices in the 21st century. Produced by the Global RIghts Project (GRIP), a research team based in the University of Rhode Island’s Center for Nonviolence and Peace Studies, the report draws on a vast quantitative human rights dataset to grade each country’s human rights practices on a 100-point scale. The report found that 60% of the world’s countries get an ‘F’ (a ...

EU funds research into causes and new therapies for multiple sclerosis

EU funds research into causes and new therapies for multiple sclerosis
2023-12-07
Multiple sclerosis (MS), an inflammatory disease of the central nervous system, affects more than 1 million people in Europe and an estimated 2.8 million worldwide. MS is characterized by an inflammation-related loss and damage of the myelin layer in the brain and spinal cord, which insulates the nerves – potentially leading to serious consequences such as paralysis or severe visual impairment.   The cause of this damage is not known. Viral infections, particularly with the Epstein-Barr virus, have been suspected for years. However, ...

MIT engineers develop a way to determine how the surfaces of materials behave

2023-12-07
Designing new compounds or alloys whose surfaces can be used as catalysts in chemical reactions can be a complex process relying heavily on the intuition of experienced chemists. A team of researchers at MIT has devised a new approach using machine learning, that removes the need for intuition and provides more detailed information than conventional methods can practically achieve. For example, applying the new system to a material that has already been studied for 30 years by conventional means, the team found the compound’s surface could form two new atomic configurations that had not previously been identified, and that one other configuration ...

LAST 30 PRESS RELEASES:

Study reports on global trends in acute kidney injury– related mortality

Study reveals a potentially better way to optimize the timing for kidney transplant waitlisting

Transitional dialysis program in Texas decreased the use of emergency dialysis

Quality improvement intervention may help prevent deaths from metformin-associated lactic acid

Conservative care versus dialysis: model indicates which is best for individual patients with advanced chronic kidney disease

Coronary artery calcium may be a predictor for all-cause mortality, including medical conditions not related to heart health

Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems

High-impact clinical trials generate promising results for improving kidney health - part 3

Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke

Triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients

Steatotic liver disease and cancer: From pathogenesis to therapeutic frontiers

SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria

Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function

Temporary benefit for immune system in early HIV treatment, but dysregulation returns

Chronic kidney disease is now the ninth leading cause of death

Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide

Participant experiences in a kidney failure care intervention in the navigate-kidney study

Community health worker support for Hispanic and Latino individuals receiving hemodialysis

Scientists unveil new strategies to balance farming and ecological protection in Northeast China

UT Health San Antonio scientist helps shape new traumatic brain injury guidelines

Rising nitrogen and rainfall could supercharge greenhouse gas emissions from the world’s largest grasslands

Study uncovers glomerular disease outcomes across the lifespan

Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats

Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering

A husband’s self-esteem may protect against preterm births, study finds

Michigan State University's James Madison College receives over $1 million to launch civic education academy

White paper on recovering from burnout through mentoring released by University of Phoenix College of Doctoral Studies

Defunct Pennsylvania oil and gas wells may leak methane, metals into water

Kessler Foundation’s John DeLuca, PhD, honored with Reitan Clinical Excellence Award from National Academy of Neuropsychology

Discordance in creatinine- and cystatin C–based eGFR and clinical outcomes

[Press-News.org] Early life gene epimutation may cause breast cancer.